Paper1999405
Purification and characterization of an oxygen-insensitive NAD(P)H nitroreductase from Enterobacter cloacae.
Bryant C and 1 other. J Biol Chem, 1991. Cited by 153 papers, by iCite.
Cite this record
ConductScience Library. Purification and characterization of an oxygen-insensitive NAD(P)H nitroreductase from Enterobacter cloacae. Papers, record 1999405. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1999405
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Purification and characterization of an oxygen-insensitive NAD(P)H nitroreductase from Enterobacter cloacae.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bacterial Proteins | Major topic |
| Enterobacter | Major topic |
| Nitroreductases | Major topic |
| Kinetics | |
| Molecular Sequence Data | |
| Molecular Weight | |
| Structure-Activity Relationship | |
| Substrate Specificity |
Source PubMed
Cited by65
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 153 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42883232 | Chemical Constructions, Mechanism and Biological Interpretation of Nitroreductase-Responsive Systems: From Hypoxia-Associated Imaging to Activatable Therapy. | Molecules | 2026 | https://conductscience.org/library/papers/42883232 | PubMed |
| 41984293 | Analysis of enzyme-based bioremediation approach in the degradation of high-energy materials (HEMs) for environmental restoration. | Environ Monit Assess | 2026 | https://conductscience.org/library/papers/41984293 | PubMed |
| 38990055 | Crystal structures of NAD(P)H nitroreductases from Klebsiella pneumoniae. | Acta Crystallogr F Struct Biol Commun | 2024 | https://conductscience.org/library/papers/38990055 | PubMed |
| 38678027 | Cyclodipeptide oxidase is an enzyme filament. | Nat Commun | 2024 | https://conductscience.org/library/papers/38678027 | PubMed |
| 38338671 | Biological Function of Prophage-Related Gene Cluster ΔVpaChn25_RS25055~ΔVpaChn25_0714 of Vibrio parahaemolyticus CHN25. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38338671 | PubMed |
| 37047042 | Hemicyanine-Based Near-Infrared Fluorescence Off-On Probes for Imaging Intracellular and In Vivo Nitroreductase Activity. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37047042 | PubMed |
| 35108777 | Biotransformation of nitro aromatic amines in artificial alkaline habitat by pseudomonas DL17. | Environ Anal Health Toxicol | 2022 | https://conductscience.org/library/papers/35108777 | PubMed |
| 34625106 | Compositional variation of the human fecal microbiome in relation to azo-reducing activity: a pilot study. | Gut Pathog | 2021 | https://conductscience.org/library/papers/34625106 | PubMed |
| 34405262 | Structural diversity, functional aspects and future therapeutic applications of human gut microbiome. | Arch Microbiol | 2021 | https://conductscience.org/library/papers/34405262 | PubMed |
| 34357428 | Diversity and abundance of the functional genes and bacteria associated with RDX degradation at a contaminated site pre- and post-biostimulation. | Appl Microbiol Biotechnol | 2021 | https://conductscience.org/library/papers/34357428 | PubMed |
| 34062712 | The Role of Nitroreductases in Resistance to Nitroimidazoles. | Biology (Basel) | 2021 | https://conductscience.org/library/papers/34062712 | PubMed |
| 33936006 | Reductive Cytochrome P450 Reactions and Their Potential Role in Bioremediation. | Front Microbiol | 2021 | https://conductscience.org/library/papers/33936006 | PubMed |
| 33918536 | The YfkO Nitroreductase from Bacillus Licheniformis on Gold-Coated Superparamagnetic Nanoparticles: Towards a Novel Directed Enzyme Prodrug Therapy Approach. | Pharmaceutics | 2021 | https://conductscience.org/library/papers/33918536 | PubMed |
| 33673069 | Nitroaromatic Antibiotics as Nitrogen Oxide Sources. | Biomolecules | 2021 | https://conductscience.org/library/papers/33673069 | PubMed |
| 33025290 | Evolutionary aspects of the Viridiplantae nitroreductases. | J Genet Eng Biotechnol | 2020 | https://conductscience.org/library/papers/33025290 | PubMed |
| 32979040 | Evaluation of two xenobiotic reductases from Pseudomonas putida for their suitability for magnetic nanoparticle-directed enzyme prodrug therapy as a novel approach to cancer treatment. | Microbiologyopen | 2020 | https://conductscience.org/library/papers/32979040 | PubMed |
| 31953608 | Asymmetric ligand binding in homodimeric Enterobacter cloacae nitroreductase yields the Michaelis complex for nitroaromatic substrates. | J Mol Model | 2020 | https://conductscience.org/library/papers/31953608 | PubMed |
| 31703334 | Degradation of High Energy Materials Using Biological Reduction: A Rational Way to Reach Bioremediation. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31703334 | PubMed |
| 30799223 | Discovery and Characterization of a Nitroreductase Capable of Conferring Bacterial Resistance to Chloramphenicol. | Cell Chem Biol | 2019 | https://conductscience.org/library/papers/30799223 | PubMed |
| 30521592 | Effects of acute exposures of 2,4,6-trinitrotoluene and inorganic lead on the fecal microbiome of the green anole (Anolis carolinensis). | PLoS One | 2018 | https://conductscience.org/library/papers/30521592 | PubMed |
Data11
The data bank entries PubMed's record names. Trial numbers are under Trials.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1999405
GET https://conductscience.org/api/papers/v1/1999405/cited_by?page=2